MYELOPROLIFERATIVE DISORDER
Clinical trials for MYELOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an enzyme shield the gut during transplant recovery?
Disease control OngoingThis study tests an oral enzyme called SYN-004 in adults who have received a stem cell transplant and need intravenous antibiotics for fever. The enzyme is designed to break down antibiotics in the gut, protecting the natural bacteria there. Researchers will check safety, whether…
Matched conditions: MYELOPROLIFERATIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Theriva Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New stem cell transplant approach shows promise for blood cancer patients without full matches
Disease control OngoingThis Phase 3 trial tested a stem cell transplant using blood stem cells from a half-matched (haploidentical) donor in 21 people with various blood cancers. The goal was to see if this approach could help patients who don't have a fully matched donor. Participants received chemoth…
Matched conditions: MYELOPROLIFERATIVE DISORDER
Phase: PHASE3 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC